Zanelli Magda, Pizzi Marco, Sanguedolce Francesca, Zizzo Maurizio, Palicelli Andrea, Soriano Alessandra, Bisagni Alessandra, Martino Giovanni, Caprera Cecilia, Moretti Marina, Masia Francesco, De Marco Loredana, Froio Elisabetta, Foroni Moira, Bernardelli Giuditta, Alvarez de Celis Maria Isabel, Giunta Alessandro, Merli Francesco, Ascani Stefano
Pathology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy.
General Pathology and Cytopathology Unit, Department of Medicine-DMED, University of Padova, 35121 Padova, Italy.
Cancers (Basel). 2021 Jul 1;13(13):3316. doi: 10.3390/cancers13133316.
Mastocytosis represents a heterogeneous group of neoplastic mast cell disorders. The basic classification into a skin-limited disease and a systemic form with multi-organ involvement remains valid. Systemic mastocytosis is a disease often hard to diagnose, characterized by different symptoms originating from either the release of mast cell mediators or organ damage due to mast cell infiltration. Gastrointestinal symptoms represent one of the major causes of morbidity, being present in 60-80% of patients. A high index of suspicion by clinicians and pathologists is required to reach the diagnosis. Gastrointestinal mastocytosis can be a challenging diagnosis, as symptoms simulate other more common gastrointestinal diseases. The endoscopic appearance is generally unremarkable or nonspecific and gastrointestinal mast cell infiltration can be focal and subtle, requiring an adequate sampling with multiple biopsies by the endoscopists. Special stains, such as CD117, tryptase, and CD25, should be performed in order not to miss the gastrointestinal mast cell infiltrate. A proper patient's workup requires a multidisciplinary approach including gastroenterologists, endoscopists, hematologists, oncologists, and pathologists. The aim of this review is to analyze the clinicopathological features of gastrointestinal involvement in systemic mastocytosis, focusing on the relevance of a multidisciplinary approach.
肥大细胞增多症是一组异质性的肿瘤性肥大细胞疾病。将其基本分类为皮肤局限性疾病和累及多器官的系统性疾病仍然有效。系统性肥大细胞增多症是一种常常难以诊断的疾病,其特征是由肥大细胞介质释放或肥大细胞浸润导致的器官损伤所引起的不同症状。胃肠道症状是发病的主要原因之一,60% - 80%的患者存在该症状。临床医生和病理学家需要高度怀疑才能做出诊断。胃肠道肥大细胞增多症的诊断具有挑战性,因为其症状与其他更常见的胃肠道疾病相似。内镜表现通常不显著或无特异性,胃肠道肥大细胞浸润可能是局灶性且不明显的,这需要内镜医生进行多次活检以获取足够的样本。应进行特殊染色,如CD117、类胰蛋白酶和CD25染色,以免遗漏胃肠道肥大细胞浸润情况。对患者进行恰当的检查需要多学科方法,包括胃肠病学家、内镜医生、血液学家、肿瘤学家和病理学家。本综述的目的是分析系统性肥大细胞增多症胃肠道受累的临床病理特征,重点关注多学科方法的相关性。